The effect of oral isotretinoin on visual contrast sensitivity and amount of lacrimation in patients with acne vulgaris.

CONTEXT: Acne vulgaris is a puberty-onset chronic inflammatory disease of the pilosebaceous unit. Isotretinoin is a derivative of vitamin A commonly used for severe and nodulocystic acne. While isotretinoin has many side effects related to the eye, visual system and lacrimation, there is no information regarding isotretinoin's influence on contrast sensitivity.

AIM: To investigate the effect of isotretinoin on visual contrast sensitivity and the amount of lacrimation.

MATERIALS AND METHODS: The study included 25 patients (16 females and 9 males) who underwent isotretinoin treatment. The treatment duration ranged from 4 to 7 months. Patients were examined both before the start and at the end of treatment using the Schirmer test in each eye. The contrast sensitivity measurement was performed both individually for each eye and in a binocular fashion using the Pelli-Robson Sensitivity Chart.

RESULTS: The results of the Schirmer test before treatment were 19.74 ± 3.63 mm for the right eye and 19.66 ± 3.63 mm for the left eye. Post-treatment measurement results were 17.24 ± 3.5 mm for the right eye and 16.68 ± 3.73 mm for the left eye. There was a statistically significant difference between the before and after treatment measurements (p < 0.000). Before treatment, contrast sensitivity was 1.45 ± 0.19 for the right eye and 1.42 ± 0.2 for the left eye. The binocular measurement was 1.54 ± 0.14. After treatment, the right eye was 1.47 ± 0.19, the left eye was 1.46 ± 0.18, and the binocular measurement was 1.54 ± 0.18. There were no statistically significant differences between before and after treatment (p > 0.05).

DISCUSSION: There are contradicting reports on the results of the Schirmer test. The only similar study that has evaluated contrast sensitivity used the drug acitretin, the results of which are consistent with those the present study.

CONCLUSION: Our study is significant in that it is the first to investigate the effects of isotretinoin on visual contrast sensitivity that is closely associated with real-world performance. Our results need to be supported by future studies.